MeMed raises $93M to accelerate commercialization of its host immune-response product portfolio
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Stay updated with breaking news from Memed Key. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
MeMed's technology rapidly distinguishes bacterial and viral infections, and can predict which Covid-19 patients need drug treatment.
MeMed Key® Wins Red Dot Award for High Design Quality April 22, 2021 07:00 ET | Source: MeMed MeMed , 2021 -frog, a leading global design and strategy consultancy, part of Capgemini Invent, and MeMed, a pioneer in the field of host immune response technology are proud to announce that MeMed Key ® has received the Red Dot Award for Product Design 2021. MeMed Key ® is a cutting-edge technology platform that allows highly sensitive and rapid measurements of multiple proteins at the point of need, empowering physicians to better diagnose and manage their patients in mu...